
About Validus Pharmaceuticals, Inc.
Validus is focused on acquiring, reformulating and
marketing prescription products relevant to the psychiatry and
neurology markets. Validus seeks to acquire mature products
that have well defined and accepted clinical utility relevant to
today’s practice of medicine.
Validus’ portfolio currently includes
Marplan®, which is indicated for the treatment of depression.
Marplan is a member of the monoamine oxidase inhibitor class of
antidepressants.
Please click below for more information about:
Equetro®
Rocaltrol®
|
CONTACT US
Customer Care Center
866-9VALIDUS
info@validuspharma.com
Headquarters
Validus Pharmaceuticals, Inc.
119 Cherry Hill Road - Suite 310
Parsippany, NJ 07054
James R. Hunter
President & CEO
Phone: 973-265-2777, ext. 109
Fax: 973-265-2770
jhunter@validuspharma.com
Lee Rios
Chief Operating Officer
Phone: 973-265-2777, ext. 118
Fax: 973-265-2770
lrios@validuspharma.com
Herbert W. Harris, MD, PhD
Chief Medical Officer
Phone: 973-265-2777, ext. 111
Fax: 973-265-2770
hharris@validuspharma.com
|